Across TCGA pan-cancer cohorts, TSPY16P RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated TSPY16P data layer.
The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher TSPY16P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated TSPY16P expression acts as an unfavorable survival marker, although some lineages such as STAD show a favorable association.
UCEC, GBM, and SKCM are the cancer types where TSPY16P RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.